1. Home
  2. ILAG vs MBIO Comparison

ILAG vs MBIO Comparison

Compare ILAG & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Living Application Group Inc.

ILAG

Intelligent Living Application Group Inc.

HOLD

Current Price

$3.76

Market Cap

8.1M

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.75

Market Cap

5.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ILAG
MBIO
Founded
1981
2015
Country
Hong Kong
United States
Employees
238
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1M
5.8M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
ILAG
MBIO
Price
$3.76
$0.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.8K
33.0K
Earning Date
04-24-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
98.99
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.53
52 Week High
$7.19
$7.00

Technical Indicators

Market Signals
Indicator
ILAG
MBIO
Relative Strength Index (RSI) 58.54 43.63
Support Level $0.44 $0.69
Resistance Level $3.97 $0.80
Average True Range (ATR) 0.20 0.04
MACD 0.01 0.01
Stochastic Oscillator 64.71 53.86

Price Performance

Historical Comparison
ILAG
MBIO

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: